1. Home
  2. INTS vs GTI Comparison

INTS vs GTI Comparison

Compare INTS & GTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTS
  • GTI
  • Stock Information
  • Founded
  • INTS 2012
  • GTI 2019
  • Country
  • INTS United States
  • GTI Malaysia
  • Employees
  • INTS N/A
  • GTI N/A
  • Industry
  • INTS Biotechnology: Pharmaceutical Preparations
  • GTI
  • Sector
  • INTS Health Care
  • GTI
  • Exchange
  • INTS Nasdaq
  • GTI NYSE
  • Market Cap
  • INTS 8.4M
  • GTI 9.5M
  • IPO Year
  • INTS 2023
  • GTI N/A
  • Fundamental
  • Price
  • INTS $0.28
  • GTI $0.14
  • Analyst Decision
  • INTS Strong Buy
  • GTI
  • Analyst Count
  • INTS 2
  • GTI 0
  • Target Price
  • INTS $6.75
  • GTI N/A
  • AVG Volume (30 Days)
  • INTS 5.7M
  • GTI 55.6M
  • Earning Date
  • INTS 08-11-2025
  • GTI 08-12-2025
  • Dividend Yield
  • INTS N/A
  • GTI N/A
  • EPS Growth
  • INTS N/A
  • GTI N/A
  • EPS
  • INTS N/A
  • GTI N/A
  • Revenue
  • INTS N/A
  • GTI N/A
  • Revenue This Year
  • INTS N/A
  • GTI N/A
  • Revenue Next Year
  • INTS N/A
  • GTI N/A
  • P/E Ratio
  • INTS N/A
  • GTI N/A
  • Revenue Growth
  • INTS N/A
  • GTI N/A
  • 52 Week Low
  • INTS $0.26
  • GTI $0.06
  • 52 Week High
  • INTS $4.94
  • GTI $4.15
  • Technical
  • Relative Strength Index (RSI)
  • INTS 35.87
  • GTI 62.95
  • Support Level
  • INTS $0.32
  • GTI $0.09
  • Resistance Level
  • INTS $0.36
  • GTI $0.17
  • Average True Range (ATR)
  • INTS 0.03
  • GTI 0.02
  • MACD
  • INTS 0.00
  • GTI 0.01
  • Stochastic Oscillator
  • INTS 1.88
  • GTI 77.27

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

About GTI GRAPHJET TECHNOLOGY

Graphjet Technology is a company that owns state-of-the-art technology for the manufacture of artificial graphene and graphite, critical raw materials used in a variety of industries. The technology was developed through our collaboration with National University of Malaysia and Universiti Teknikal Malaysia Melaka. It produces artificial graphite and graphene from palm seed kernels, a waste product widely available in Malaysia and other countries that produce palm seed oil. Unlike mineral coal-based or petroleum-based graphite which is ultimately limited and must be mined and processed to produce commercial-grade graphite, our raw materials are renewable and effectively unlimited.

Share on Social Networks: